Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Phibro Animal Health's EPS (Basic) for the
three
months ended in Jun. 2026 was $0.54.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $2.46.
During the past 12 months, Phibro Animal Health's average EPS without NRIGrowth Rate was 54.10% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 38.60% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 18.80% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 3.10% per year.
During the past 13 years, Phibro Animal Health's highest 3-Year average EPS without NRI Growth Rate was 73.40% per year. The lowest was -10.60% per year. And the median was 2.15% per year.
Phibro Animal Health (NAS:PAHC) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Phibro Animal Health Earnings per Share (Diluted) Related Terms
Phibro Animal Health Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Phibro Animal Health's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health Earnings per Share (Diluted) Chart
PAHC vs XERS, HROW, ANIP: Earnings per Share (Diluted) Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phibro Animal Health PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's PE Ratio distribution charts can be found below:
* The bar in red indicates where Phibro Animal Health's PE Ratio falls into.
Phibro Animal Health Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Phibro Animal Health's Earnings Per Share (Diluted) for the fiscal year that ended in Jun. 2026 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $2.44 mean?
Phibro Animal Health (PAHC) has a Earnings per Share (Diluted) of $2.44 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Phibro Animal Health and its competitors. According to the industry distribution chart, Phibro Animal Health ranks #138 out of 785 companies in the Drug Manufacturers industry, placing it in the top 17.6%.
Is Phibro Animal Health's Earnings per Share (Diluted) too high?
Phibro Animal Health's current Earnings per Share (Diluted) is $2.44. The Drug Manufacturers industry median Earnings per Share (Diluted) is 9.90. Phibro Animal Health's value of $2.44 is 75.4% below this industry median. Based on the distribution chart, Phibro Animal Health ranks #138 out of 785 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Phibro Animal Health has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Phibro Animal Health's Earnings per Share (Diluted) compare to XERS and HROW?
According to the Drug Manufacturers industry distribution chart, Phibro Animal Health ranks #138 out of 785 companies for Earnings per Share (Diluted). This places Phibro Animal Health in the top 18% of its industry — outperforming the majority of peers. The industry median Earnings per Share (Diluted) is 9.90. Phibro Animal Health's value of $2.44 is 75.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Drug Manufacturers company?
The median Earnings per Share (Diluted) among Drug Manufacturers companies is 9.90, based on 785 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phibro Animal Health's current Earnings per Share (Diluted) of $2.44 is 75.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Phibro Animal Health and its competitors. For the Drug Manufacturers industry, the median Earnings per Share (Diluted) is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phibro Animal Health's current Earnings per Share (Diluted) is $2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phibro Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Phibro Animal Health (PAHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $31.34, compared to a current price of $38.29 — trading 22.2% above its estimated fair value. The current Earnings per Share (Diluted) is $2.44 and 75.4% below the Drug Manufacturers industry median of 9.90. Phibro Animal Health's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Phibro Animal Health (PAHC), the current Earnings per Share (Diluted) is $2.44 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phibro Animal Health (PAHC) Overvalued in 2026?
Based on GuruFocus' analysis, Phibro Animal Health stock appears to be overvalued.
The current stock price of $38.29 is trading 22.2% above its estimated GF Value™ of $31.34.
GuruFocus considers Phibro Animal Health to be Modestly Overvalued.
Key valuation signals for PAHC:
Earnings per Share (Diluted): $2.44
GF Value™: $31.34 vs. price of $38.29 (22.2% above fair value)
Industry Position: 75.4% below the Drug Manufacturers median (#138 of 785)
No single metric tells the full story. See the PAHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
70GF Score
Get the complete analysis for PAHC
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PAHC has been successfully added to your 
